Products for Research Use Only

Trans-Nerolidol

CAT: 0804-HY-N6635-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N6635-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Trans-Nerolidol improves the anti-proliferative effect of Doxorubicin (DOX) against intestinal cancer and breast cancer cells in vitro. trans-Nerolidol increases accumulation of DOX inside cells in vitro. trans-Nerolidol activates apoptosis in vivo[1].
CAS Number
40716-66-3
UNSPSC
12352211
Hazard Statement
H317, H319, H410
Target
Fungal
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/trans-nerolidol.html
Purity
97.58
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C=CC(C)(O)CC/C=C(C)/CC/C=C(C)/C
Molecular Formula
C15H26O
Molecular Weight
222.37
Precautions
H317, H319, H410
References & Citations
[1]Hanušová V, et al. The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice. Biomed Pharmacother. 2017 Nov;95:828-836.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Natural Products
Clinical Information
No Development Reported